On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with a new kind of pump technology in the Twiist device.

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from ... like hyperglycemia, diabetic ketoacidosis, or death.

Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.

Insulin pumps dose insulin throughout the day to help people with diabetes keep their glucose levels in target. It's a common misconception that people with diabetes who use a pump "have it ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because ... potentially leading to diabetic ketoacidosis ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

From hiking in Myanmar and camping in Mongolia to diving in Thailand and even a 10-day silent retreat in India, Krista ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective lowered by Canaccord ... The company's flagship ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...